v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating Activities:    
Net loss $ (11,713) $ (21,495)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 1,299 1,140
Inventory impairment 511 2,272
Non-cash lease activity 134 154
Bad debt expenses (recoveries) 15 41
Deferred income tax (income) expense (47) 62
Share-based compensation 1,665 3,382
Loss (gain) on disposal of equipment (33) 322
Loss on financing transaction 0 1,553
Change in fair value of warrants liabilities 0 (39)
Other income (expense), net 0 1,430
Change in fair value of convertible notes 0 475
Increase (decrease) in cash resulting from changes in:    
Trade accounts receivable (847) 1,561
Inventories 135 256
Other current assets 264 68
Other noncurrent assets (129) 3
Trade accounts payable (263) (1,479)
Income taxes payable (59) (932)
Contract liabilities 772 (1,461)
Other current liabilities (124) 131
Right of use liabilities (138) (159)
Accrued expenses (130) (2,814)
Contract liabilities, noncurrent 668 (38)
Net cash provided by (used in) operating activities (8,020) (15,567)
Investing Activities:    
Capital expenditures (1,631) (2,667)
Proceeds from sale of equipment 24 0
Net cash provided by (used in) investing activities (1,607) (2,667)
Financing Activities:    
Proceeds from issuances of common stock and Pre-funded warrants 30,872 22,784
Tax payments associated with equity-based compensation transactions (1,116) 0
Repayments of lines of credit 0 (622)
Net cash provided by (used in) financing activities 29,584 21,587
Net increase/(decrease) in cash, cash equivalents, and restricted cash equivalents 19,957 3,353
Cash, cash equivalents, and restricted cash equivalents beginning of period 4,508 1,155
Cash, cash equivalents, and restricted cash equivalents end of the period 24,465 4,508
Reconciliation of cash, cash equivalents and restricted cash equivalents at end of period:    
Cash and cash equivalents 24,365 4,358
Restricted cash equivalents included in other current assets 100 150
Cash, cash equivalents, and restricted cash equivalents end of the period 24,465 4,508
Supplemental cash flow information:    
Interest paid 0 63
Income tax paid, net of refunds received 73 2,331
Non-cash investing and financing activities:    
Settlement of vendor liability with share issuance 36 0
Sale of equipment 11 0
Conversion of convertible notes 0 6,170
Conversion of Legacy SMAP promissory loan into common stock 0 200
Shares issued for Equity Line of Credit commitment fee 0 500
Inducement shares from Financing Transaction 0 1,381
Nonrelated Party    
Financing Activities:    
Repayments of promissory notes $ (172) $ (575)